Use

Type 1 diabetes is caused by the autoimmune destruction of insulin-producing pancreatic beta cells, leading to insulin deficiency. Serological markers, such as autoantibodies to tyrosine phosphatase (IA2), are pivotal in the prediction and diagnosis of type 1 diabetes as they appear long before clinical symptoms. These autoantibodies provide early evidence of the autoimmune process against pancreatic islet cells and are present in 50% to 75% of patients with type 1 diabetes at or before disease onset. Their presence, especially when combined with other antibodies like those against glutamic acid decarboxylase (GAD) and insulin, significantly enhances the predictive value for diabetes.